Emergence of Novel Norovirus GII.4 Variant

Preeti Chhabra*, Damien C. Tully, Janet Mans, Sandra Niendorf, Leslie Barclay, Jennifer L. Cannon, Anna M. Montmayeur, Chao Yang Pan, Nicola Page, Rachel Williams, Helena Tutill, Sunando Roy, Cristina Celma, Stuart Beard, Michael L. Mallory, Gédéon Prince Manouana, Thirumalaisamy P. Velavan, Ayola Akim Adegnika, Peter G. Kremsner, Lisa C. LindesmithStéphane Hué, Ralph S. Baric, Judith Breuer, Jan Vinjé

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Abstract

    We detected a novel GII.4 variant with an amino acid insertion at the start of epitope A in viral protein 1 of noroviruses from the United States, Gabon, South Africa, and the United Kingdom collected during 2017–2022. Early identification of GII.4 variants is crucial for assessing pandemic potential and informing vaccine development.

    Original languageEnglish
    Pages (from-to)163-167
    Number of pages5
    JournalEmerging Infectious Diseases
    Volume30
    Issue number1
    DOIs
    Publication statusPublished - Jan 2024

    Bibliographical note

    Publisher Copyright:
    © 2024 Centers for Disease Control and Prevention (CDC). All rights reserved.

    Fingerprint

    Dive into the research topics of 'Emergence of Novel Norovirus GII.4 Variant'. Together they form a unique fingerprint.

    Cite this